Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer.
John LB, Howland LJ, Flynn JK, West AC, Devaud C, Duong CP, Stewart TJ, Westwood JA, Guo ZS, Bartlett DL, Smyth MJ, Kershaw MH, Darcy PK.
John LB, et al. Among authors: stewart tj.
Cancer Res. 2012 Apr 1;72(7):1651-60. doi: 10.1158/0008-5472.CAN-11-2788. Epub 2012 Feb 7.
Cancer Res. 2012.
PMID: 22315352